Vivatides Therapeutics
Woburn
About Vivatides Therapeutics
Vivatides Therapeutics develops new RNA treatments to help improve patients' lives using biotechnology research.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $10.0M
- Funding stage: Seed
- Last round: Seed (Feb 2025)
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/vivatides-therapeutics-82930 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.